NEW YORK, Feb 25 (Reuters) – The $72 million verdict this week against Johnson & Johnson in a U.S. case alleging links between talc-based powder and ovarian cancer has prompted global headlines,…
The post Big verdict doesn’t assure more wins for plaintiffs in talc-cancer cases appeared first on NASDAQ.